NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy
Journal of Surgical Oncology · 2026-11 · 134 (6) · 947-957
DOI: 10.1002/jso.70359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 16.08.2026. Verfasst von Frank G Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Gastrectomy, Stomach Neoplasms, Laparoscopy, Robotic Surgical Procedures. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background
ACS‐NSQIP began capturing operative approach in 2022. With increased adoption of minimally invasive (MIS) techniques for malignancy, a contemporary review of benchmark outcomes for open, laparoscopic and robotic gastrectomy is warranted.
Methods
We performed a retrospective cohort study of adults in ACS‐NSQIP (2022–2024) undergoing partial or total gastrectomy (CPT 43631‐4 and 43620‐2) for cancer. Outcomes included operative time, length of stay (LOS), unplanned conversion‐to‐open, and 30‐day morbidity, mortality, and readmission. Multivariable logistic regression evaluated patient and operative factors associated with morbidity.
Results
Among 1,459 patients (median age 66, 60.4% male), 66.8% underwent partial gastrectomy and 33.2% total gastrectomy. Approaches were 61.2% open, 19.5% laparoscopic, and 19.3% robotic. Thirty‐day mortality (1.8%), major complications (18.2%), and readmissions (10.3%) did not differ by approach. Unplanned conversion‐to‐open occurred in 14.0% of MIS. Robotic had longer median operative time of +1.2 and +1.7 h than laparoscopic and open and median −1 and −2 days shorter LOS respectively ( p < 0.001). Hypoalbuminemia (OR 3.10), CKD ≥ 3 (OR 1.75), and anemia (OR 1.48) were independently associated with major complications ( p < 0.05).
Conclusion
Operative approach influences operative time and LOS but not short‐term morbidity and mortality. The newly available ACS‐NSQIP operative approach variable enables approach‐specific benchmarks for cancer‐related gastrectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, Minnesota, USA.
- Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Frank G Lee, Kristine T Hanson, Ashton E Cross, Elizabeth B Habermann, Cornelius A Thiels, Travis E Grotz
Zitieren
APA
Lee, F. G., Hanson, K. T., Cross, A. E., Habermann, E. B., Thiels, C. A., & Grotz, T. E. (2026). NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy. Journal of Surgical Oncology, 134(6), 947-957. https://doi.org/10.1002/jso.70359
Vancouver
Lee FG, Hanson KT, Cross AE, Habermann EB, Thiels CA, Grotz TE. NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy. Journal of Surgical Oncology. 2026;134(6):947-957. doi:10.1002/jso.70359
BibTeX
@article{Lee2026,
author = {Lee, Frank G and Hanson, Kristine T and Cross, Ashton E and Habermann, Elizabeth B and Thiels, Cornelius A and Grotz, Travis E},
title = {NSQIP Outcomes for Open and Minimally Invasive Gastrectomy for Malignancy},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {134},
number = {6},
pages = {947--957},
doi = {10.1002/jso.70359}
}
EUVIMED